GlassScriptPhysician profile
John C Peterson
NPI 1508880642
$2,823.98
in general payments reported to CMS, 2019-2025
18 companies · $725 in 2025
The $725 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $219 · 2021: $543 · 2022: $364 · 2023: $345 · 2024: $504 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,424.46 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $370.45 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Astellas Pharma US INC | $234.35 | 2021-2025 | Veozah |
| Allergan, INC. | $131.66 | 2020 | |
| Vifor Pharma, INC. | $125.00 | 2019 | |
| Phathom Pharmaceuticals, INC. | $112.64 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.78 | 2022-2025 | Xifaxan |
| Arbor Pharmaceuticals, INC. | $55.98 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $55.86 | 2025 | Rexulti |
| Exact Sciences Corporation | $53.08 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $50.10 | 2024 | Auvelity |
| Pfizer INC. | $30.83 | 2025 | |
| Vanda Pharmaceuticals INC. | $26.26 | 2025 | Fanapt, Hetlioz |
| Valinor Pharma, LLC | $20.12 | 2025 | Movantik |
| Amgen INC. | $15.35 | 2023 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.42 | 2023 | |
| Novo Nordisk INC | $14.17 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.